Scientists identify progenitor cells, potential new 'roots' of breast cancer

October 29, 2012
Scientists discover potential new ‘roots’ of breast cancer

Scientists have discovered new types of early cells in mammary glands, uncovering clues to the origins of different breast cancers - and potential new drug targets, according to findings published in Breast Cancer Research.

The team at Cancer Research UK's Cambridge Research Institute identified at least two types of early cells, called progenitor cells. Unlike stem cells, which can develop into any type of cell and keep on dividing, progenitor cells can only divide a limited number of times. Previously scientists only knew of one type of progenitor cells in .

Cancer is thought to begin in cells that can produce many , which form the tumour mass. So different progenitor cells may explain why there are different types of breast cancer.

The team discovered that one group of progenitor cells, called oestrogen positive progenitors, had oestrogen receptors. This protein receives signals from the sex hormone, oestrogen. The other group - oestrogen negative cells - lacked this receptor.

Oestrogen positive progenitor cells survive better in a low oestrogen and progesterone environment - similar to the of post-menopausal women. This suggests that tumours in post-menopausal women may develop from these cells, but further experiments are needed to confirm this.

The oestrogen negative progenitor cells have a resembling an aggressive type of breast cancer called basal-like breast cancer, more likely to affect younger women. This suggests the disease may develop from the oestrogen negative progenitors.

Study author, Dr John Stingl, at Cancer Research UK's Cambridge Research Institute, said: "This exciting discovery reveals that mammary glands are much more complicated than scientists initially thought. Uncovering new types of 'mother' cells may explain why there are different types of , and why young and older women tend to get different types. It could also provide new starting points for ways to diagnose and treat the disease in the future."

Dr Julie Sharp, Cancer Research UK's senior science information manager, said: "This research takes us right to the root of how breast cells develop. This fresh understanding could reveal new ways to block the development of cancer and tell us more about what happens when tumours become resistant to treatment.

Explore further: Scientists find new drug target in breast cancer

More information: Phenotypic and functional characterization of the luminal cell hierarchy of the mammary gland. Breast Cancer Research. Mona Shehata et al.

Related Stories

Scientists find new drug target in breast cancer

May 22, 2011

Researchers have identified a new protein involved in the development of drug resistance in breast cancer which could be a target for new treatments, they report today in the journal Nature Medicine.

Silencing a deadly conversation in breast cancer

June 2, 2011

While it is already known that breast cancer cells create the conditions for their own survival by communicating their needs to the healthy cells that surround them, Australian researchers have identified a new way of turning ...

Recommended for you

Combination therapy can prevent cytostatic resistance

November 26, 2015

Researchers at Karolinska Institutet have found a new way of preventing resistance to cytostatics used in the treatment of cancers such as medulloblastoma, the most common form of malignant brain tumour in children. The promising ...

Forecasting the path of breast cancer in a patient

November 23, 2015

USC researchers have developed a mathematical model to forecast metastatic breast cancer survival rates using techniques usually reserved for weather prediction, financial forecasting and surfing the Web.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.